{"id":"https://openalex.org/W46539950","doi":null,"title":"HLA and drug-induced toxicity.","display_name":"HLA and drug-induced toxicity.","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W46539950","mag":"46539950","pmid":"https://pubmed.ncbi.nlm.nih.gov/19479656"},"language":"en","primary_location":{"id":"pmid:19479656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19479656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[{"id":"https://openalex.org/I2799740997","display_name":"Royal Perth Hospital","ror":"https://ror.org/00zc2xc51","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2799740997","https://openalex.org/I2800882159","https://openalex.org/I4388446364","https://openalex.org/I4405257575"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Elizabeth J Phillips","raw_affiliation_strings":["Royal Perth Hospital and PathWest, Department of Clinical Immunology and Immunogenetics, Western Australia, Australia. e.phillips@iiid.com.au"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Perth Hospital and PathWest, Department of Clinical Immunology and Immunogenetics, Western Australia, Australia. e.phillips@iiid.com.au","institution_ids":["https://openalex.org/I2799740997"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070165631","display_name":"Simon Alexander Mallal","orcid":"https://orcid.org/0000-0002-7036-1309","observed_orcids":["https://orcid.org/0000-0002-7036-1309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon A Mallal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.2716,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.95528844,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"11","issue":"3","first_page":"231","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hla-alleles","display_name":"HLA alleles","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.9449999928474426},{"id":"https://openalex.org/keywords/severe-cutaneous-adverse-reactions","display_name":"severe cutaneous adverse reactions","score":0.8420000076293945},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9599999785423279},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":1.0},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacogenetic-screening","display_name":"pharmacogenetic screening","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.9675965309143066},{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.6929486989974976},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.644140899181366},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5475704073905945},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.4992213249206543},{"id":"https://openalex.org/C41007239","wikidata":"https://www.wikidata.org/wiki/Q18026920","display_name":"HLA-B","level":4,"score":0.46410784125328064},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4251840114593506},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33643943071365356},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.15092340111732483},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.10185465216636658},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.08797767758369446},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.08056792616844177},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000099227","descriptor_name":"Abacavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005820","descriptor_name":"Genetic Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006649","descriptor_name":"Histocompatibility Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:19479656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19479656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:alma.61MUN_INST:11137357610007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/HLA-and-drug-induced-toxicity/991005545997207891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:2835","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/2835/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Phillips, E.J. <http://researchrepository.murdoch.edu.au/view/author/Phillips, Elizabeth.html> and Mallal, S. <http://researchrepository.murdoch.edu.au/view/author/Mallal, Simon.html> (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.","raw_type":"Journal Article"},{"id":"mag:46539950","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19479656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W101990696","https://openalex.org/W2158079639","https://openalex.org/W2108336316","https://openalex.org/W2767755825","https://openalex.org/W4210367063","https://openalex.org/W2156404814","https://openalex.org/W2331235899","https://openalex.org/W2108685428","https://openalex.org/W1976076283","https://openalex.org/W2064239366"],"abstract_inverted_index":{"The":[0,82],"discovery":[1],"of":[2,18,25,37,59,84,90,108,142,164,178],"new":[3],"associations":[4,41],"between":[5],"drug":[6,52,65],"toxicities":[7],"and":[8,22,61,71,78,145,151],"specific":[9],"HLA":[10,27],"alleles":[11],"has":[12,96,120,135],"been":[13,43,136],"facilitated":[14],"by":[15,76,132,138],"the":[16,23,57,88,106,126,139,162,174,182],"use":[17,58],"DNA-based":[19],"molecular":[20],"techniques":[21],"introduction":[24],"higher-resolution":[26],"typing,":[28],"which":[29],"have":[30,42],"replaced":[31],"serological":[32],"typing":[33],"in":[34,157,181],"this":[35],"field":[36],"study.":[38],"Drug":[39],"toxicity/HLA":[40],"best":[44],"documented":[45],"for":[46,87,117,149,161,167,173],"immunologically":[47],"mediated":[48],"reactions,":[49,66],"such":[50,67],"as":[51,68,170,172],"hypersensitivity":[53,92],"reactions":[54],"associated":[55],"with":[56,122],"abacavir,":[60],"severe":[62],"cutaneous":[63],"adverse":[64],"Stevens-Johnson":[69],"syndrome":[70,93],"toxic":[72],"epidermal":[73],"necrolysis":[74],"induced":[75],"carbamazepine":[77],"allopurinol":[79],"use,":[80],"respectively.":[81],"implementation":[83,163,177],"HLA-B*5701":[85,115,150,165],"screening":[86,107,116,166,180],"prevention":[89],"abacavir":[91],"(ABC":[94],"HSR)":[95],"provided":[97],"a":[98,158],"model":[99],"approach":[100],"that":[101],"can":[102],"be":[103],"applied":[104],"to":[105],"other":[109],"drugs.":[110],"High-level":[111],"clinical":[112],"evidence":[113],"supporting":[114],"ABC":[118],"HSR":[119],"converged":[121],"experimental":[123],"findings":[124],"characterizing":[125],"CD8+T-cell":[127],"HLA-B*5701-restricted":[128],"immune":[129],"response":[130],"triggered":[131],"abacavir.":[133],"This":[134],"followed":[137],"successful":[140,176],"development":[141],"simplified":[143],"inexpensive":[144],"quality-assured":[146],"laboratory":[147],"tests":[148],"ongoing":[152],"quality":[153],"assurance":[154],"programs,":[155],"resulting":[156],"paradigm":[159],"both":[160],"HIV":[168],"providers":[169],"well":[171],"broader":[175],"pharmacogenetic":[179],"clinic.":[183]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}